Urban Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Urban Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$580K	Buy	+6,215	New	+$495K	0.48%	53

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

MCM

Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Urban Wealth Management's ARKG Position: Q4 2020 in Review

Urban Wealth Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q4 2020: 6,215 shares worth $580K. The stake represents 0.48% of the portfolio and ranks #53 among its holdings.

414 funds tracked by Wall St. Rank hold ARKG as of Q4 2020.

Urban Wealth Management held 6,215 shares of ARK Genomic Revolution ETF worth $580K as of Q4 2020.
ARK Genomic Revolution ETF was a new Urban Wealth Management position in Q4 2020.
ARK Genomic Revolution ETF made up 0.48% of Urban Wealth Management's portfolio in Q4 2020, its #53 holding.
414 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2020.

Based on Urban Wealth Management's 13F filing for Q4 2020, filed 17 Feb 2021.